The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin

Interindividual variation in response to metformin, first-line therapy for type 2 diabetes, is substantial. Given that transporters are determinants of metformin pharmacokinetics, we examined the effects of promoter variants in both multidrug and toxin extrusion protein 1 (MATE1) (g.−66T→C, rs225228...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stocker, Sophie L., Morrissey, Kari M., Yee, Sook Wah, Castro, Richard A., Xu, Lu, Dahlin, Amber, Ramirez, Andrea H., Roden, Dan M., Wilke, Russ A., McCarty, Cathy A., Davis, Robert L., Brett, Claire M., Giacomini, Kathleen M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671611/
https://ncbi.nlm.nih.gov/pubmed/23267855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.210
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller